Page last updated: 2024-08-21

durapatite and rifampin

durapatite has been researched along with rifampin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's9 (81.82)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Chang, KM; Figurski, D; Fine, DH; Furgang, D; Goncharoff, P; Schreiner, H1
Ishimaru, D; Ito, Y; Ogawa, H; Shimizu, K1
Devaraj, SN; Girija, EK; Kalkura, SN; Raja, SB; Savithri, K; Sridevi, TS; Thamizhavel, A; Vani, R1
Dong, J; Du, Y; Liu, H; Liu, Y; Ma, J; Zhang, S1
Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF1
Jiang, D; Liu, Y1
Jiang, D; Liu, Y; Zhu, J1
Cui, X; Li, BN; Li, G; Li, L; Ma, YG; Shi, F; Wang, F; Wang, H; Wang, L; Weng, J; Zhang, C; Zhou, CX; Zhou, Z1
Jiang, D; Liang, Q; She, S; Song, X; Wang, C; Wang, Z1
Amarnath Praphakar, R; Rajan, M; Sam Ebenezer, R; Shakila, H; Sumathra, M; Vignesh, S1
Kumar, A; Lidgren, L; Matheshwaran, S; Murugan, PA; Nair, NN; Qayoom, I; Raina, DB; Tägil, M; Teotia, AK; Verma, R1

Reviews

1 review(s) available for durapatite and rifampin

ArticleYear
Surgical treatment of an infant with Bacille Calmette-Guérin osteomyelitis extending across the growth plate.
    Orthopedics, 2011, Jan-03, Volume: 34, Issue:1

    Topics: Anti-Bacterial Agents; BCG Vaccine; Bone Substitutes; Curettage; Durapatite; Growth Plate; Humans; Infant; Isoniazid; Knee Joint; Male; Meta-Analysis as Topic; Osteomyelitis; Pyrazinamide; Recurrence; Reoperation; Rifampin; Tibia

2011

Other Studies

10 other study(ies) available for durapatite and rifampin

ArticleYear
Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats.
    Archives of oral biology, 2001, Volume: 46, Issue:11

    Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Analysis of Variance; Animals; Antibiotics, Antitubercular; Antibodies, Bacterial; Bacterial Adhesion; Cells, Cultured; Colony Count, Microbial; Drug Resistance, Bacterial; Durapatite; Ecology; Epithelial Cells; Food Microbiology; Germ-Free Life; Humans; Linear Models; Male; Mouth; Mouth Mucosa; Phenotype; Rats; Rats, Sprague-Dawley; Rifampin; Saliva; Statistics, Nonparametric; Stomach

2001
Surfactant free rapid synthesis of hydroxyapatite nanorods by a microwave irradiation method for the treatment of bone infection.
    Nanotechnology, 2011, Jul-15, Volume: 22, Issue:28

    Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Bone Diseases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; Durapatite; Escherichia coli; Humans; Microbial Sensitivity Tests; Microwaves; Nanotechnology; Nanotubes; Rifampin; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Surface-Active Agents; X-Ray Diffraction

2011
Preparation, characterization, and in vitro cytotoxicity evaluation of a novel anti-tuberculosis reconstruction implant.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Drug Compounding; Drug Implants; Durapatite; Mice; Microscopy, Electron, Scanning; Nanocomposites; Osteoblasts; Polyesters; Porosity; Rifampin; Spectroscopy, Fourier Transform Infrared; Tuberculosis, Osteoarticular; X-Ray Diffraction

2014
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus

2015
Effect of bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres on bone and joint tuberculosis in vitro.
    Cell biology international, 2017, Volume: 41, Issue:4

    Topics: Cell Differentiation; Cell Line, Tumor; Drug Carriers; Durapatite; Humans; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis, Osteoarticular; Wnt Signaling Pathway

2017
Release characteristics of bone‑like hydroxyapatite/poly amino acid loaded with rifapentine microspheres in vivo.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Alanine Transaminase; Amino Acids; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Bone and Bones; Creatinine; Disease Models, Animal; Durapatite; Male; Microspheres; Organ Specificity; Rabbits; Rifampin

2017
A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
    Biomaterials, 2018, Volume: 176

    Topics: Animals; Antitubercular Agents; Biocompatible Materials; Bone Regeneration; Cell Adhesion; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Drug Therapy, Combination; Durapatite; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Polyvinyl Alcohol; Prostheses and Implants; Rabbits; Rifampin; Tissue Scaffolds; Tuberculosis, Osteoarticular

2018
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Adipocytes; Animals; Antitubercular Agents; Calcium Phosphates; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Durapatite; Female; Microspheres; Particle Size; Rabbits; Rifampin; Structure-Activity Relationship; Surface Properties

2019
Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.
    International journal of pharmaceutics, 2019, Jun-30, Volume: 565

    Topics: Animals; Antitubercular Agents; Carrageenan; Cell Line; Drug Delivery Systems; Drug Liberation; Durapatite; Erythrocytes; Hemolysis; Humans; Isoniazid; Klebsiella pneumoniae; Macrophages; Maleic Anhydrides; Mice; Nanocomposites; Osteoblasts; Osteomyelitis; Regeneration; Rifampin; Staphylococcus aureus; Tuberculosis

2019
A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
    Scientific reports, 2020, 08-24, Volume: 10, Issue:1

    Topics: Antitubercular Agents; Biofilms; Bone Regeneration; Calcium Sulfate; Computational Biology; Delayed-Action Preparations; Drug Carriers; Drug Interactions; Drug Therapy, Combination; Durapatite; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Rifampin; Tuberculosis, Osteoarticular

2020